9:00-10:00 

REGISTRATION OF PARTICIPANTS

Andreyevskiy Ballroom

10:00 -11:45

WELCOMING ADDRESS

Dmitry Kostennikov – State Secretary/Deputy Minister of Health of the Russian Federation

Melita Vujnovic- Special WHO Representative to the Russian Federation;

Natalia Stadchenko – Chair of the Federal Compulsory Medical Insurance Fund;

Valery Ryazanskiy –  Chair of the Committee for Social Policy of the Federation Council;

Dmitry Morozov  – Chair of the Committee for Health Protection of the State Duma;

Representatives of executive authorities of the CIS and EAEU countries

Representative of the European Network for Health Technology Assessment (EUnetHTA)

11:45 - 12:00

Coffee break  

12:00 -14:00

Health technology assessment in the CIS countries

1. 1.     Political and socio-economic prerequisites for establishing HTA at the national level - Vitaly Omelyanovskiy, General Director of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
2. 2.     International experience of HTA integration exemplified by the European Network for Health Technology Assessment (EUnetHTA) – Niklas Hedberg, Chief Pharmacist and Chair of EUnetHTA Executive Board
3. 3.     Global HTA evolution in fast-developing healthcare – Alicia Granados, First President of HTAi)
4. 4.     HTA system in Russia: realities and perspectives – Elena Maksimkina,  Director of the Department for Drug Provision and Medical Product Circulation Control of the Ministry of Health of the Russian Federation
5. 5.     HTA development in Kazakhstan  – Adlet Tabarov, Head of the Center for Rational Use of Drugs and Medical Technologies of the Republican Center for Health Development of the Ministry of Healthcare of the Republic of Kazakhstan
6. 6.     HTA development in Belorussia – Irina Kozhanova, senior researcher of the laboratory for health technology assessment standardization fundamentals of the Republican Scientific and Practical Center of Health Technologies, Informatization, Management and Economics of Public Health.
7. 7.      Perspectives for HTA integration in the CIS countries - Georgy Khachatryan – Head of the Department for HTA Methodological Support of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

14:00 – 15:00

LUNCH 

15:00 – 16:30

Clinical guidelines  

1. 1.     Global achievements in the developing and implementing of clinical guidelines: are Russia and the CIS countries ready to join the evidence-based ecosystem?  - Per Olav Vandvic, ​ professor of medicine,  Institute of Health and Society, University of Oslo Norway, The Guidelines International Network (G-I-N)
2. 2.     Role and place of clinical guidelines in UK’s healthcare. Experience of NICE –Irina Voicechovskaya, Scientific Adviser, The National Institute for Health and Care Excellence (NICE)
3. 3.     Implementation of clinical guidelines and protocols in the Kyrgyz Republic  – Bermet Baryktybasova, evidence-based medicine expert, the Ministry of Health of the Kyrgyz Republic  
4. 4.     Implementation of clinical practice guidelines in Azerbaijan: ensuring access to high quality healthcare in terms of the development of compulsory medical insurance – Nabil Seyidov, manager of the Department for Healthcare Policy and Reforms of the Center for Public Healthcare and Reforms of the Ministry of Health of the Republic of Azerbaijan
5. 5.     Digital ‘live’ Cochrane systematic reviews and reliable clinical guidelines: global standards and opportunities for Russia and the CIS countries  –Linn Brandt,  Institute of Health and Society, University of Oslo Norway and the MAGIC Evidence Ecosystem Foundation/ Liliya Ziganshina, Director of Cochrane Russia, Professor of the Kazan (Volga Regional) Federal University
6. 6.     Role of clinical guidelines in the organizing and funding of medical care  – the way the system will develop - Vitaly Omelyanovskiy, General Director of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

16:30 -17:00

Conclusion 

17:00 -17:30

Drinks reception 

Niklas Hedberg, Executive Board Chair, EUnetHTA - International HTA integration experience. The example of EUnetHTA

Niklas Hedberg is the Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency (TLV), in Sweden.

Niklas is the Chair of the EUnetHTA Executive Board. As the TLV lead partner in EUnetHTA, Niklas has been a member of the Executive Board since June 2016 and he is the chair since May 2018.

Niklas has been worked with the national pricing and reimbursement decision making for pharmaceutical products since 2001 and for medical devices since 2009. He has a broad experience of different aspects of value based evaluation and over time has seen the increasing importance for health technology assessment (HTA) both across health care systems and on local level to prepare accurate decision making.

Between August 2009 and March 2014 Niklas was the Head of Department in the Department for Pharmaceutical Submissions at TLV. From 2001 to 2009 he held positions as investigator, medical assessor and project leader in the agency.

Niklas graduated from Uppsala University with a Master of Science in Pharmacy degree in 1999 and after that worked a couple of years in the pharmaceutical industry before joining the governmental agency.

MS Irina Voicechovskaja, Scientific Advisor, NICE Scientific Advice

Irina is responsible for a delivery of scientific advice and business development projects within the Scientific Advice programme at NICE. Prior to joining the Scientific Advice team, Irina worked for the Technology Appraisal programme at NICE where she led on development of technology appraisal guidelines. Before joining NICE Irina worked in different settings including public and private sectors in the UK and Lithuania. Most recently she worked at a consultancy Optimity Advisors where Irina was responsible for research and evaluation work on various health topics for public sector organisations across the UK and European Union.

Irina holds BSc and MSc in Public Health from Vilnius University as well as a Postgraduate diploma in Pharmacoepidemiology and Pharmacovigilance from London School of Hygiene and Tropical Medicine.